These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8683585)

  • 1. Selection of chymotrypsin inhibitors from a conformationally-constrained combinatorial peptide library.
    McBride JD; Freeman N; Domingo GJ; Leatherbarrow RJ
    J Mol Biol; 1996 Jun; 259(4):819-27. PubMed ID: 8683585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of chymotrypsin inhibitors from a second-generation template assisted combinatorial peptide library.
    McBride JD; Freeman HN; Leatherbarrow RJ
    J Pept Sci; 2000 Sep; 6(9):446-52. PubMed ID: 11016881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of threonine in the P2 position of Bowman-Birk proteinase inhibitors: studies on P2 variation in cyclic peptides encompassing the reactive site loop.
    McBride JD; Brauer AB; Nievo M; Leatherbarrow RJ
    J Mol Biol; 1998 Sep; 282(2):447-58. PubMed ID: 9735299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors.
    Weder JK; Hinkers SC
    J Agric Food Chem; 2004 Jun; 52(13):4219-26. PubMed ID: 15212472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and analysis of novel bicyclic and bifunctional protease inhibitors.
    Jaulent AM; Leatherbarrow RJ
    Protein Eng Des Sel; 2004 Sep; 17(9):681-7. PubMed ID: 15486024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the synthesis of proteinase inhibitors. II. Synthesis of cyclic nonapeptide fragments and analogs related to the reactive sites of soybean Bowman-Birk inhibitor.
    Terada S; Sato K; Kato T; Izumiya N
    Int J Pept Protein Res; 1980 May; 15(5):441-54. PubMed ID: 7440053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a mixture of cyclic peptides based on the Bowman-Birk reactive site loop to screen for serine protease inhibitors.
    Domingo GJ; Leatherbarrow RJ; Freeman N; Patel S; Weir M
    Int J Pept Protein Res; 1995 Jul; 46(1):79-87. PubMed ID: 7558601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase inhibition using small Bowman-Birk-type structures.
    Fernandez JH; Mello MO; Galgaro L; Tanaka AS; Silva-Filho MC; Neshich G
    Genet Mol Res; 2007 Oct; 6(4):846-58. PubMed ID: 18058707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide mimics of the Bowman-Birk inhibitor reactive site loop.
    McBride JD; Watson EM; Brauer AB; Jaulent AM; Leatherbarrow RJ
    Biopolymers; 2002; 66(2):79-92. PubMed ID: 12325158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic peptide template combinatorial libraries: synthesis and identification of chymotrypsin inhibitors.
    Eichler J; Lucka AW; Houghten RA
    Pept Res; 1994; 7(6):300-7. PubMed ID: 7888713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
    Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
    J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of serine proteinase inhibitors by combinatorial chemistry using trypsin inhibitor SFTI-1 as a starting structure.
    Zabłotna E; Jaśkiewicz A; Łegowska A; Miecznikowska H; Lesner A; Rolka K
    J Pept Sci; 2007 Nov; 13(11):749-55. PubMed ID: 17828796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and bio-assay of RCM-derived Bowman-Birk inhibitor analogues.
    Miles SM; Leatherbarrow RJ; Marsden SP; Coates WJ
    Org Biomol Chem; 2004 Feb; 2(3):281-3. PubMed ID: 14747852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic peptide mimics of the Bowman-Birk inhibitor protein.
    McBride JD; Leatherbarrow RJ
    Curr Med Chem; 2001 Jul; 8(8):909-17. PubMed ID: 11375759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete substitutional analysis of a sunflower trypsin inhibitor with different serine proteases.
    Hilpert K; Hansen G; Wessner H; Volkmer-Engert R; Höhne W
    J Biochem; 2005 Oct; 138(4):383-90. PubMed ID: 16272132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structural basis of a conserved P2 threonine in canonical serine proteinase inhibitors.
    Brauer AB; Nievo M; McBride JD; Leatherbarrow RJ
    J Biomol Struct Dyn; 2003 Apr; 20(5):645-56. PubMed ID: 12643767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and identification of variants with improved purification yield of Bowman-Birk protease inhibitors carrying protein binding loops.
    Collier KD; Vogtentanz G; Amin NS; Estabrook M; Estell DA; Fox B; Power SD; Rao R; Schmidt BF
    Protein Expr Purif; 2009 Dec; 68(2):146-60. PubMed ID: 19686850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
    Azim MK; Grossmann JG; Zaidi ZH
    J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfide bond mutagenesis and the structure and function of the head-to-tail macrocyclic trypsin inhibitor SFTI-1.
    Korsinczky ML; Clark RJ; Craik DJ
    Biochemistry; 2005 Feb; 44(4):1145-53. PubMed ID: 15667208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary structure of Dioclea glabra trypsin inhibitor, DgTI, a Bowman-Birk inhibitor.
    Bueno NR; Fritz H; Auerswald EA; Mentele R; Sampaio M; Sampaio CA; Oliva ML
    Biochem Biophys Res Commun; 1999 Aug; 261(3):838-43. PubMed ID: 10441512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.